Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-02-27 | Ms. Michelle D. GreeneExec. VP and Chief Information Officer of Global Technology & Business Services | -2,75k | 627,39k | Verkauf | 228,47 - 228,55 | 12,23k | -18,34% |
| 2026-02-18 | Mr. Aaron E. AltCFO | -2,33k | 524,96k | Verkauf | 225,50 | 0,00 | -100,00% |
| 2026-02-15 | Mr. Aaron E. AltCFO | -1,91k | 422,59k | Sale to Issuer | 220,79 | 0,00 | -100,00% |
| 2026-02-06 | Ms. Patricia Arlene Hemingway HallIndependent Chairman of the Board | -4,00k | 918,88k | Verkauf | 229,72 | 10,58k | -27,44% |
| 2025-12-01 | Ms. Deborah L. WeitzmanCEO of Pharmaceutical & Specialty Solutions Segment | -551,00 | 116,96k | Sale to Issuer | 212,26 | 52,88k | -1,03% |
| 2025-12-01 | Ms. Jessica L. MayerChief Legal & Compliance Officer | -422,00 | 89,57k | Sale to Issuer | 212,26 | 12,98k | -3,15% |
| 2025-12-01 | Ms. Ola M. SnowInsider | -320,00 | 67,92k | Sale to Issuer | 212,26 | 15,25k | -2,05% |
| 2025-12-01 | Mr. Stephen M. MasonCEO of GMPD segment | -595,00 | 126,29k | Sale to Issuer | 212,26 | 25,49k | -2,28% |
| 2025-12-01 | Ms. Mary C. SchererSenior VP & CAO | -61,00 | 12,95k | Sale to Issuer | 212,26 | 3,50k | -1,72% |
| 2025-08-20 | Ms. Deborah L. WeitzmanCEO of Pharmaceutical & Specialty Solutions Segment | -21,37k | 3,22M | Verkauf | 150,53 | 53,43k | -28,57% |
| 2025-08-20 | Mr. Jason M. HollarCEO & Director | -35,90k | 5,39M | Verkauf | 149,40 - 150,40 | 107,40k | -25,05% |
| 2025-08-19 | Ms. Michelle D. GreeneExec. VP and Chief Information Officer of Global Technology & Business Services | -13,50k | 2,01M | Verkauf | 148,76 - 149,28 | 14,98k | -47,41% |
| 2025-08-15 | Ms. Michelle D. GreeneExec. VP and Chief Information Officer of Global Technology & Business Services | -9,97k | 1,50M | Sale to Issuer | 150,22 | 14,98k | -39,96% |
| 2025-08-19 | Ms. Mary C. SchererSenior VP & CAO | -6,77k | 1,01M | Verkauf | 149,25 | 3,56k | -65,55% |
| 2025-08-15 | Ms. Mary C. SchererSenior VP & CAO | -2,57k | 386,37k | Sale to Issuer | 150,22 | 3,56k | -41,97% |
| 2025-08-19 | Mr. Stephen M. MasonCEO of GMPD segment | -41,58k | 6,19M | Verkauf | 147,87 - 149,39 | 26,09k | -61,45% |
| 2025-08-15 | Mr. Stephen M. MasonCEO of GMPD segment | -30,81k | 4,63M | Sale to Issuer | 150,22 | 26,09k | -54,15% |
| 2025-08-19 | Mr. Jason M. HollarCEO & Director | -107,71k | 16,04M | Verkauf | 148,15 - 149,45 | 143,30k | -42,91% |
| 2025-08-15 | Mr. Jason M. HollarCEO & Director | -136,41k | 20,49M | Sale to Issuer | 150,22 | 143,30k | -48,77% |
| 2025-08-15 | Ms. Deborah L. WeitzmanCEO of Pharmaceutical & Specialty Solutions Segment | -24,13k | 3,62M | Sale to Issuer | 150,22 | 74,80k | -24,39% |
| 2025-08-19 | Ms. Jessica L. MayerChief Legal & Compliance Officer | -38,08k | 5,67M | Verkauf | 148,08 - 149,52 | 27,01k | -58,50% |
| 2025-08-15 | Ms. Jessica L. MayerChief Legal & Compliance Officer | -27,93k | 4,20M | Sale to Issuer | 150,22 | 27,01k | -50,83% |
| 2025-08-19 | Ms. Ola M. SnowInsider | -28,15k | 4,19M | Verkauf | 148,86 - 149,39 | 15,58k | -64,38% |
| 2025-08-15 | Ms. Ola M. SnowInsider | -18,19k | 2,73M | Sale to Issuer | 150,22 | 15,58k | -53,87% |
| 2025-08-19 | Mr. Aaron E. AltCFO | -48,24k | 7,18M | Verkauf | 148,61 - 149,19 | 0,00 | -100,00% |
| 2025-08-15 | Mr. Aaron E. AltCFO | -34,87k | 5,24M | Sale to Issuer | 150,22 | 0,00 | -100,00% |
| 2025-06-30 | Mr. Stephen M. MasonCEO of GMPD segment | -5,69k | 951,92k | Sale to Issuer | 167,18 | 34,98k | -14,00% |
| 2025-06-30 | Ms. Jessica L. MayerChief Legal & Compliance Officer | -5,18k | 865,32k | Sale to Issuer | 167,18 | 29,53k | -14,91% |
| 2025-06-30 | Mr. Jason M. HollarCEO & Director | -5,82k | 973,15k | Sale to Issuer | 167,18 | 80,12k | -6,77% |
| 2025-06-30 | Ms. Ola M. SnowInsider | -3,62k | 605,69k | Sale to Issuer | 167,18 | 23,69k | -13,27% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
